Nutra Pharma Corp (NPHC) Cash from Operations (2010 - 2026)

Nutra Pharma has disclosed Cash from Operations across 17 years of filings, most recently posting -$251223.0 for Q2 2026.

• In Q2 2026, Cash from Operations rose 12.88% year-over-year to -$251223.0; the TTM figure through Jun 2026 stood at -$1.0 million (down 23.12% YoY), while the FY2025 annual figure was -$1.2 million, down 174.55% from the prior year.
• Cash from Operations came in at -$251223.0 for Q2 2026 at Nutra Pharma, up from -$327791.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of $19073.0 in Q3 2024 to a low of -$405006.0 in Q1 2025.
• Average Cash from Operations over 5 years is -$193300.3, with a median of -$186535.0 recorded in 2023.
• Year-over-year, Cash from Operations surged 122.65% in 2024 and tumbled 1414.79% in 2025.
• Over 5 years, Cash from Operations stood at -$54032.0 in 2022, then tumbled by 244.66% to -$186229.0 in 2023, then increased by 4.31% to -$178210.0 in 2024, then decreased by 23.35% to -$219818.0 in 2025, then fell by 14.29% to -$251223.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were -$251223.0 in Q2 2026, -$327791.0 in Q1 2026, and -$219818.0 in Q4 2025.